determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …

Aims Pulmonary embolism (PE) is the third most common cardiovascular cause of death;
systemic thrombolysis is potentially lifesaving treatment in patients presenting with …

Background European estimates of the burden imposed by pulmonary embolism are not
available to this date. We aimed to assess pulmonary embolism-related mortality and time …

Aims Patients with acute pulmonary embolism (PE) classified as low risk by the Pulmonary
Embolism Severity Index (PESI), its simplified version (sPESI), or the Hestia criteria may be …

Background: The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is
unknown. Objectives: This study investigated the long-term prognosis of patients with …

The efficient progress in nanotechnology has transformed many aspects of food science and
the food industry with enhanced investment and market share. Recent advances in …

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary
embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent …

Venous thromboembolism (VTE) is a major preventable disease that affects hospitalized
inpatients. Risk stratification and prophylactic measures have good evidence supporting …

Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most
frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …